NEPHRO CARE INDIA LIMITED Quarterly Results (NEPHROCARE) — Q4 FY26

Revenue trend and demand read-through

Topline for Q4 FY26 came in at ₹20.75 cr, and ₹22.66 cr in the preceding Q3 FY26 quarter.

On a sequential basis revenue declined -8.5%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.

Total expenses for the quarter were ₹24.28 cr, or 117.0% of revenue.

Margins, tax and profitability

Net profit of ₹1 cr works out to a net margin of 4.8%.

Below the operating line, NEPHRO CARE INDIA LIMITED reported profit before tax of ₹1.3 cr, a tax charge of ₹0.29 cr (effective rate 22.6%), interest cost of -₹0.01 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.

Sequentially, net profit moved from ₹0.42 cr in Q3 FY26 to ₹1 cr in Q4 FY26, a change of +138.6%.

Trailing twelve months and annual context

On a full-year basis, FY26 revenue was ₹84.71 cr with net profit of ₹3.37 cr and EPS of —, versus the prior year where revenue grew +84.0% and profit declined -7.4%.

What to watch in the next NEPHROCARE quarter

For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A single weak quarter matters less than the direction over three to four consecutive quarters.

NEPHRO CARE INDIA LIMITED has not yet intimated its next results date to the exchange. This page refreshes automatically from filings and the board-meeting calendar, so the tables above will reflect the next quarter as soon as it is reported.

All figures here are as reported to the exchanges and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.